Skip to main content

Sterility Testing by Direct Inoculation Method

Sterility Testing by Direct Inoculation Method

Direct Inoculation Method
Learn the procedure for sterility test for sterile pharmaceutical products by direct inoculation method.

1.0 Objective

To lay down Standard Operating Procedure is to provide guidelines for sterility testing by Direct Inoculation Method.

2.0 Scope

This procedure is applicable for the products manufactured at the location which can not be tested by Membrane Filtration Method.

3.0 Responsibility

Implementation: Microbiologist

4.0 Accountability

Execution: Manager - QC

Review & Approval : AGM - QA / QC

Procedure

Direct Inoculation Method

Sample for Finished Products: Collect the samples to be tested for sterility. Out of the whole sample, randomly select 20 articles of each lot of batch for both LVP and SVP t erminally sterilized products and for aseptically filled products.

  Sample for Intermediates: Randomly collect 16 pre-sterilized bottle samples to be tested for sterility from LVP bottle pack machine separately in such a way that each bottle should represent each cavity of the mold of bottle pack machine.

Transfer the samples to QC department in clean plastic crates.

Wipe the sample article individually with 70% IPA solution and keep in a clean stainless steel tray marked with Product Name, Batch No and  Lot No, and then transfer the samples to the sterility room through clean pass box for performing sterility.

Prepare the media tubes (FTM and SCDM) as per the SOP for preparation of culture media, dispense 100-100 ml quantity in test tubes & plug them (for oily products add 10-10 g/l Polysorbate 80 to FTM & SCDM). Sterilize both the media at 121ºC and 15 psi pressure for 20 minutes as per SOP for Media Sterilization by Autoclaving.

After autoclaving Label the tubes with Name of Media, Media Batch No. and pre-incubate the media tubes at appropriate temperature i.e. SCDM tubes at 20 to 25ºC whereas FTGM tubes at 30 to 35ºC for 24 - 48 hrs before subjecting them for sterility operations.

Autoclave Dress & a conical flask with a cotton plug in an S.S Container separately at 121ºC temperature and 15 psi pressure for 30 minutes  as per SOP. Autoclave 100 ml of WFI at 121ºC 15 psi pressure for 20 minutes for negative control.

Transfer the pre-incubated sterile media tubes, SCDA plates, sterile swabs to the sterility test room through pass box.

Enter in sterility room as per the Entry / Exit procedure for Sterility Room.

Start the LAF as per SOP for operating Instruction for LAF.

Wipe out all samples to be tested for sterility with 70% IPA solution.

Before starting sterility test, expose the SCDA plates as specified locations throughout the testing as per SOP.

Check the Manometer reading of working LAF and check the temperature as well as humidity of the sterility room Manometer reading of working LAF chamber pressure should be between 08 – 15mm of water. Temperature reading of the sterility room should be 27ºC ± 2ºC.

Cut the tip of bottle or ampoule with sterile SS blade in front of the gas burner and immediately transfer the whole content of the ampoule for SVP to sterile conical flask aseptically. Similarly, transfer the content of all 20 ampoules to the sterile conical flask & mix.

Now take 10 ml sample from the conical flask & transfer to 100 ml sterile FTM tube. Similarly, transfer 10 ml sample to 100 ml sterile SCDM tube.

Label both the tubes with the product name, B. No, lot No., date of testing, Completion date & Tested by.

Simultaneously prepare a negative control by transferring 10-10 ml sterile WFI to 100-100 ml sterile FTM & SCDM tubes and label both the tubes as a Negative control.

Simultaneously prepare a chamber control during the sterility take two tubes, one is SCDM & other one is FTM tube, unplug the cotton plug of the tube and expose in LAF during sterility, after completion of sterility replug the tubes and then incubate the tubes as a chamber control.

After completion of work transfer all inoculated media through hatch box and then transfers all the equipment and exposed plates to microbiology analysis section.

Immediately move from the sterility area as per exit procedure specified SOP for Entry-Exit Procedure for Sterility Room.

Incubate the FTM tubes at 30ºC – 35ºC and SCDM tubes at 20ºC – 25ºC for 14 days. The incubation period for terminally sterilized products is not less than 7 days and 14 days for aseptically filled products as per IP. If the Product is as per USP, BP, incubation period is 14 days for both terminally sterilized as well as for aseptically filled products.

Start the LAF of Microbiology Analysis room as per SOP and prepare four positive Control tubes by inoculating aseptically 10 to 100 cfu in FTM tubes with S. aureus NCIM 2079, P. aeruginosa NCIM 2200, B. subtilis NCIM 2063 and environmental flora. Similarly prepare three SCDM positive control by inoculating approx 10 to 100 cells separately with C. albicans NCIM 3471, A. niger NCIM 1196 and environmental flora. Incubate FTM positive control tubes at 30 – 35ºC for 3 days & SCDM positive control tubes at 20 – 25ºC for 5 days.

Observation and Interpretation of Results

Visually examine the media tubes daily to its conclusion for macroscopic evidence of microbial growth.

If no evidence of growth observed in any of the tube the product to be examined for the test complies with the test for sterility.

The test is not valid unless the negative control shows negative till at end of incubation, and positive control shows growth within specified incubation period.

Destroy all the positive controls after confirmation of growth in both FTM and SCDM tubes.

If evidence of microbial growth is found in any of the tubes, investigate the cause of its failure as per SOP for Sterility test failure investigation. If investigation report concludes that test is invalid, repeat the test with 20 units.

If no evidence of growth is found in the repeat test the product examined complies with the test for sterility. If evidence of microbial growth is found in the repeat test the product examined does not comply with the test for sterility.

Precaution

Sample bottles/ vials should be wiped properly with filtered 70% IPA before transferring them to sterility room and also inside the sterility room before sterility operations. Pass box should also be cleaned properly with filtered 70% IPA solution.

Any material used in the sterility operation or inside sterility room should be autoclaved properly.

The tip of sample bottles/ vials should be heated properly in front of gas burner before cutting with a sterile heated cutting blade.

Clean the waste solution reservoir immediately after sterility operations and mop the outer surface of the reservoir with filtered 70% IPA with sterile mopper.

6.0 Abbreviation

SOP: Standard Operating Procedure 

QA: Quality Assurance

QC: Quality Control 

NA: Not Applicable

IPA: Isopropyl Alcohol

SVP: Small volume Parenterals

 LVP: Large volume Parenterals

FTM: Fluid Thioglycollate Medium 

SCDM: Soybean casein digest medium 

IP: Indian Pharmacopoeia

BP: British Pharmacopoeia

USP: United States Pharmacopoeia

Comments

  1. I like your all post. You have done really good work. Thank you for the information you provide, it helped me a lot. I hope to have many more entries or so from you.
    Very interesting blog.
    beecrack.com
    svp-pro Crack

    ReplyDelete

Post a Comment

If you have any doubts, please let me know

Popular posts from this blog

Checklist for Audit in Sterile Area

Checklist for Audit in Sterile Area Checklist to verify the sterile manufacturing area before the audit. 1. Is there any SOP giving details for activity/ movement in the sterile area. 2. Verify the suitability of system for sanitization of hands. 3. Is there the SOP on entry-exit; gowning and de-gowning into the critical area available? 4. Verify the availability of following records:  Air pressure differential  Particulate monitoring  Temperature  Humidity  Microbiological monitoring by settle plate 5. Are these records available and maintained as per SOPs? 6. Check the above mentioned individual records. Are the entries within specifications mentioned in SOP/ MTPs. 7. Is the controlled copy of MTP pertaining to monitoring by settle plate available to plant person? 8. Are the location for settle plates identified and the chart/ layout available with plant? 9. Are the following areas monitored for parameters mentioned in step 4:  Air-lock to the critical ar...

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals Validation of sterile manufacturing process by media fill validation test as per PICS guidelines for aseptic validation or aseptic process simulation. 1.0 OBJECTIVE 1.1 To define procedures for validating and maintaining the validation of all aseptic filling processes and qualification of the quality of the product by system/facility/equipment. 2.0 SCOPE 2.1 This procedure applies to all aseptically filled sterile products intended for human use. 3.0 RESPONSIBILITY 3.1 The Validation personnel coordinate the aseptic filling validation program and write the sterile media aseptic filling processes reports. 3.2 Manufacturing personnel the sterile media aseptic filling processes and performs the sterile media fills. 3.3 QA personnel perform the sampling and assist with the IPQA monitoring required for each sterile media fill. 3.4 QC personnel to perform the testing and assist with the monitoring required fo...

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing Know about sterile pharmaceutical production using Blow Fill Seal (BFS) and Form Fill Seal (FFS) technology. Both of these techniques are used to manufacture  sterile pharmaceutical products   as parenteral (LVP & SVP), infusions, ophthalmic and inhalation products. These are automated techniques to prepare sterile products. The basic concept of the  FFS   and BFS is to reduce the  contamination   by forming the container, filling and sealing in a closed sterile chamber of the machine. There is no personnel intervention to reduce the chances of the contamination during the manufacturing of sterile products. It gives more production at very low operational cost with the high assurance of  sterility . Blow fill seal technology is widely used and accepted by the various pharmaceutical regulatory authorities as US-FDA and MHRA. The system is being used for over 30 years a...

Steps for HPLC Method Development

Steps for HPLC Method Development Know about the different steps of the HPLC analytical method development in pharmaceutical analysis. Analytical method development is considered as a critical process in pharmaceuticals. Availability of the different types of columns, operating  parameters, mobile phase composition, diluent and pH values make it critical to develop an analytical method. A good analytical method should be  simple, used column, mobile phase and buffer should be common. It can be done easily step by step. Following are the common HPLC method development steps. 1. Selection of HPLC Analytical Method 2. Selection of Chromatographic Conditions 3. Parameter Optimization 1. Selection of HPLC Analytical Method: First of all consult the literature that is available on the product. It will help you to understand the nature of  the product that will help to select the different parameters. A. Sample Preparation: Select method to prepare the sample according to its ...

Good Regulatory practices

(Good Regulatory practices) Good Regulatory practices (documentation, licenses, renewals, e-governance) in Community Pharmacy, Hospital pharmacy, Pharma Manufacturing, Wholesale business, inspections, import, export of drugs and medical devices. Good Regulatory practices: Introduction: Good Regulatory Practices (GRP) is processes, systems, tools, and methods for improving the quality of regulations that are internationally recognised. Before government initiatives are implemented, GRP systematically implements public consultation and stakeholder involvement, as well as impact analysis of government proposals to ensure they are fit for purpose and will achieve the goals set out. Objectives: GRP provide a means of establishing sound and effective oversight of medical products as an important part of health system performance and sustainability. If consistently and effectively implemented, they can lead to higher quality regulation, improved regulatory decision-making and compliance, incr...